Position in IVVD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$137,421
+$89,546 QoQ
Shares Held
157,594
+99.2% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 124 holders
Holding Since
Sep 2021
16 quarters on record
Voting authority
Sole 26%
Shared 0%
None 74%
Common Shares in IVVD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. IVVD ranks #262 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in IVVD
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $137,421 | 157,594 | Shares | Sole | 2026-08-12 | |
| 2025-03-31 | $47,875 | 79,133 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $42,425 | 95,768 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $99,372 | 97,424 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $92,418 | 84,017 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $8,227 | 1,853 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $28,576 | 7,253 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $12,330 | 7,253 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $12,108 | 11,532 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $99,940 | 83,284 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $121,906 | 81,271 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $253,207 | 80,897 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $248,240 | 75,683 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $243,134 | 53,319 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $165,934 | 22,856 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $955,722 | 22,626 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||